G3 Genomics is a venture studio focused exclusively on life science tools, diagnostics, and genomics. We build and operate specialized companies that design, manufacture, and commercialize molecular reagents and platforms for laboratories worldwide.  We are expanding into different sectors of life sciences and genomics in 2026 and beyond.

We combine hands‑on operating experience in qPCR, NGS, and molecular platforms with institutional‑grade finance and governance. Our model is to create independent operating companies and support them with shared expertise in capital strategy, manufacturing, and commercial execution.

Portfolio companies

Bandit Biosystems (Bandit Bio) – Supplies SeqOnce™ qPCR panels and NGS library preparation kits that help labs run more samples, generate cleaner data, and manage costs with confidence.

CrestForge –  Contract manufacturing services for reagent kits and molecular products. Research & development for advanced molecular platforms.

What we focus on

Company creation and structured acquisitions around high‑value molecular technologies.

Embedded operating support across finance, capital strategy, manufacturing, and commercial execution.

Capital‑efficient growth based on recurring consumables revenue and clear unit economics.

G3 Genomics

Org chart

Teams

Offices